Fund shareholders of Day One Biopharmaceuticals Inc
ISIN US23954D1090 · United States
- Fund shareholders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- ≈ 139.8K $ 119K €
A single tracked fund declares this company. So these figures do not say who owns it.
2 funds hold this company. This table lists the 1 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 119K € | 0.14 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.63 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.63 % | as of Sep 30, 2025 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.14 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 140 | -46 | 17,832,555 | -17.9 % |
| 2026Q1 | 186 | -1 | 21,732,676 | -15.5 % |
| 2025Q4 | 187 | 0 | 25,720,719 | -8.2 % |
| 2025Q3 | 187 | 0 | 28,022,927 | -0.5 % |
| 2025Q2 | 187 | -1 | 28,172,415 | -2.5 % |
| 2025Q1 | 188 | -4 | 28,881,560 | +9.2 % |
| 2024Q4 | 192 | +12 | 26,438,325 | +37.7 % |
| 2024Q3 | 180 | +3 | 19,197,485 | -3.0 % |
| 2024Q2 | 177 | +8 | 19,794,606 | -1.0 % |
| 2024Q1 | 169 | 0 | 19,986,768 | +4.4 % |
| 2023Q4 | 169 | 19,149,117 |
Institutional managers
198 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,044,487 | 151M $ | as of Mar 31, 2026 |
| GLAZER CAPITAL, LLC | 4,683,687 | 100.4K $ | as of Mar 31, 2026 |
| FIL Ltd | 4,131,907 | 88.6M $ | as of Mar 31, 2026 |
| Kryger Capital LLC | 3,896,485 | 83.5M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,723,131 | 79.8M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 3,134,753 | 67.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,869,876 | 61.5M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,625,235 | 56.3M $ | as of Mar 31, 2026 |
| AQR Arbitrage LLC | 2,462,154 | 52.8M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,305,123 | 49.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,954,735 | 41.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 1,954,552 | 41.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,927,557 | 41.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,902,868 | 40.8M $ | as of Mar 31, 2026 |
| O'Connor Alternative Investments LLC | 1,867,553 | 40M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 1,823,998 | 39.1M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,755,799 | 37.6M $ | as of Mar 31, 2026 |
| ODDO BHF ASSET MANAGEMENT SAS | 1,550,000 | 33.2M $ | as of Mar 31, 2026 |
| SOROS FUND MANAGEMENT LLC | 1,539,100 | 33M $ | as of Mar 31, 2026 |
| First Trust Capital Management L.P. | 1,496,007 | 32.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,296,984 | 27.8M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,214,783 | 11.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 979,238 | 21M $ | as of Mar 31, 2026 |
| DAFNA Capital Management LLC | 978,463 | 21M $ | as of Mar 31, 2026 |
| WATER ISLAND CAPITAL LLC | 944,247 | 20.2M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Day One Biopharmaceuticals Inc". https://titelia.com/en/stocks/day-one-biopharmaceuticals-inc-US23954D1090